Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
18.82
-0.63 (-3.24%)
Dec 29, 2025, 4:00 PM EST

SHE:301408 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2018 - 2019
7,4244,4126,380---
Upgrade
Market Cap Growth
55.05%-30.85%----
Upgrade
Enterprise Value
8,0354,5796,088---
Upgrade
Last Close Price
18.5610.9415.67---
Upgrade
PE Ratio
40.3032.0455.64---
Upgrade
PS Ratio
1.440.971.68---
Upgrade
PB Ratio
3.442.143.23---
Upgrade
P/TBV Ratio
10.974.655.02---
Upgrade
P/FCF Ratio
11.6410.81----
Upgrade
P/OCF Ratio
9.677.7248.57---
Upgrade
EV/Sales Ratio
1.561.011.60---
Upgrade
EV/EBITDA Ratio
13.2217.4735.41---
Upgrade
EV/EBIT Ratio
26.4620.5140.46---
Upgrade
EV/FCF Ratio
12.6011.21----
Upgrade
Debt / Equity Ratio
0.650.600.650.810.760.16
Upgrade
Debt / EBITDA Ratio
2.322.383.581.942.230.85
Upgrade
Debt / FCF Ratio
2.213.00-11.035.59-
Upgrade
Asset Turnover
1.000.961.061.441.441.64
Upgrade
Inventory Turnover
3.693.754.014.504.134.63
Upgrade
Quick Ratio
0.590.700.970.730.690.84
Upgrade
Current Ratio
1.091.191.441.251.261.62
Upgrade
Return on Equity (ROE)
9.93%7.54%8.05%18.50%9.30%14.14%
Upgrade
Return on Assets (ROA)
3.67%2.96%2.62%6.26%4.11%6.47%
Upgrade
Return on Capital (ROIC)
5.50%4.26%3.78%9.20%6.07%9.97%
Upgrade
Return on Capital Employed (ROCE)
10.60%8.40%5.70%18.70%9.80%17.00%
Upgrade
Earnings Yield
2.51%3.12%1.80%---
Upgrade
FCF Yield
8.59%9.25%-1.41%---
Upgrade
Dividend Yield
0.54%0.91%0.64%---
Upgrade
Payout Ratio
30.42%40.66%12.81%2.57%6.23%7.77%
Upgrade
Buyback Yield / Dilution
0.10%-2.43%-15.59%-3.02%2.92%-5.34%
Upgrade
Total Shareholder Return
0.63%-1.51%-14.95%-3.02%2.92%-5.34%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.